Skip to content

Zurn Elkay Water Solutions

US · ZWS #1680 by market cap Listed 1970
46.48 -1.37 -2.86%
Live - 5344 symbols - heartbeat 93s ago · 2026-10-08 07:58
Pre-market 46.48 0.00%
After-hours 46.48 0.00%
Market cap
7.71B
P/B
4.65
EPS
1.15
Reader sentiment Are you bullish or bearish on ZWS?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 4.82 In line with history 66th percentile
5-year average 6.79 · #10 of 16 in Pollution & Treatment Controls
P/E ratio 29.75 Cheap vs history 8th percentile
5-year average 40.10 · forward 26.39 · #3 of 4 in Pollution & Treatment Controls
P/S ratio 4.47 Expensive vs history 71st percentile
5-year average 3.92 · forward 4.18 · #10 of 18 in Pollution & Treatment Controls

Morningstar

★★☆☆☆ Fair value46.04 Economic moatWide UncertaintyMedium

Trading 0.9% above Morningstar's fair value estimate.

Fair value

Zurn Elkay Water Solutions Corp receives a 2-star quantitative star rating, indicating our belief that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 4% premium over our quantitative fair value estimate of $46.04 per share; however, this estimate should be taken with a pinch of salt due to its medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics undermine our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 21.0% lies in the bottom 20% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are overvalued.

The company's balance sheet is an additional cause for concern. Low leverage can limit a company's ability to invest in growth, potentially reducing shareholder value compared with a balanced use of debt and equity financing. The firm's EBITDA/interest coverage ratio of 18.2, for example, lies in the top 45% compared with peers globally. The company may have too conservative of a balance sheet based on its high EBITDA/interest coverage ratio, potentially underinvesting in growth opportunities and undermining the long-term trajectory of cash flows. This characteristic further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's wide quantitative moat rating suggests a strong ability to maintain superior profitability thanks to competitive advantages that could persist up to two decades. This is supported by the company's strong financial health score, which indicates a low likelihood that the company will tumble into financial distress.

By Quantitative Equity Report

Quote time 2026-10-08 07:58:28 · For reference only, not investment advice and not tailored to your situation.